Cost-effectiveness of digoxin versus beta blockers in permanent atrial fibrillation: the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) randomised trial

Authors

Dipak Kotecha (ORCID: https://orcid.org/0000-0002-2570-9812)
Samir Mehta (ORCID: https://orcid.org/0000-0001-7096-513X)
Karina V Bunting (ORCID: https://orcid.org/0000-0003-4602-4377)
A. John Camm (ORCID: https://orcid.org/0000-0002-2536-2871)
Kazem Rahimi (ORCID: https://orcid.org/0000-0002-4807-4610)
Mary Stanbury
Sue Jowett (ORCID: https://orcid.org/0000-0001-8936-3745)
Zainab Abdali (ORCID: https://orcid.org/0000-0002-2736-5427)
Sandra Haynes

Institutions

University Hospitals Birmingham NHS Foundation Trust (GB)
St George's, University of London (GB)
University of Oxford (GB)
Cancer Research UK Clinical Trials Unit (GB)
NIHR Birmingham Biomedical Research Centre (GB)
University of Birmingham (GB)

Publication Details

Journal: Heart
Published: 2025-01-16
DOI: https://doi.org/10.1136/heartjnl-2024-324761
Citations: 3
Primary Topic: Atrial Fibrillation Management and Outcomes
Type: article
Field-Weighted Citation Impact: 4.16

Funders

British Heart Foundation
Medical Research Council
Birmingham Biomedical Research Centre

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Cost-effectiveness of digoxin versus beta blockers in permanent atrial fibrillation: the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) randomised trial

Dipak Kotecha, Samir Mehta, Karina V Bunting, A. John Camm et al.

Jan 16, 2025

3 citations

Heart

Atrial Fibrillation Management and Outcomes

4.16

article

Cost-effectiveness of digoxin versus beta blockers in permanent atrial fibrillation: the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) randomised trial

Dipak Kotecha, Samir Mehta, Karina V Bunting, A. John Camm, Kazem Rahimi, Mary Stanbury, Sue Jowett, Zainab Abdali, Sandra Haynes

January 16, 2025article en

3 citations

Abstract

No abstract available for this paper.

HeartVol. 111(8)

University Hospitals Birmingham NHS Foundation Trust (GB), St George's, University of London (GB), University of Oxford (GB), Cancer Research UK Clinical Trials Unit (GB), NIHR Birmingham Biomedical Research Centre (GB), University of Birmingham (GB)

British Heart Foundation, Medical Research Council, Birmingham Biomedical Research Centre

Openalex Percentile: Top 7%

Atrial Fibrillation Management and Outcomes

4.16

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cost-effectiveness of digoxin versus beta blockers in permanent atrial fibrillation: the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) randomised trial — Dipak Kotecha, Samir Mehta, et al. · Heart (2025) | TGRS Research Map | TGRS